Professor Julian R. Jones, FREng, FIMMM

Co-Founder & Chair, Scientific Advisory Board

World-leading biomaterials scientist, pioneer of bioactive glass technologies, and founder of multiple translational biomaterials programmes.

Professor Julian Jones is an internationally recognised leader in materials science and regenerative medicine, he is widely regarded as one of the pioneers of bioactive glass technologies and has spent more than two decades advancing the science and clinical translation of regenerative biomaterials for bone and soft tissue repair.

Professor Jones is Professor of Biomaterials at Imperial College London and has built a world-leading research programme focused on the development of bioactive materials that stimulate tissue regeneration and healing. His research has generated fundamental advances in the understanding of how bioactive glasses interact with cells and tissues, leading to the development of novel biomaterial platforms with applications spanning orthopaedics, dentistry and regenerative medicine.

Professor Jones has advised government agencies, international scientific societies, healthcare technology funding bodies and industrial partners worldwide, helping to shape the development and translation of advanced biomaterials.

Throughout his career, Professor Jones has published extensively in leading scientific journals, supervised numerous doctoral and postdoctoral researchers, and secured substantial research funding from UK and international funding bodies. His work has been recognised globally through invited keynote lectures, prestigious awards and leadership roles within the biomaterials and tissue engineering communities.

As a Co-Founder of Bounce Biomedical, Professor Jones provides strategic scientific leadership and guides the continued development of the company’s Bouncy Bioglass™ platform. As Chair of the Scientific Advisory Board, he works closely with the executive team to ensure that the company’s technologies remain at the forefront of regenerative orthopaedic research while maintaining a clear pathway toward clinical and commercial impact.

His vision of combining advanced materials science with practical medical innovation continues to shape Bounce Biomedical’s mission to develop transformative regenerative therapies for patients with cartilage, bone and musculoskeletal disorders.